Literature DB >> 33775912

The emerging regulatory roles of long non-coding RNAs implicated in cancer metabolism.

Yongcan Xu1, Mantang Qiu2, Minmin Shen3, Shunli Dong4, Guochao Ye1, Xuefei Shi5, Ming Sun6.   

Abstract

Compared to normal cells, cancer cells exhibit specific metabolic characteristics that facilitate the growth and metastasis of cancer. It is now widely appreciated that long non-coding RNAs (lncRNAs) exert extensive regulatory effects on a spectrum of biological processes through diverse mechanisms. In this review, we focus on the rapidly advancing field of lncRNAs and summarize the relationship between the dysregulation of lncRNAs and cancer metabolism, with a particular emphasis on the specific roles of lncRNAs in glycolysis, mitochondrial function, glutamine, and lipid metabolism. These investigations reveal that lncRNAs are a key factor in the complexity of malignant cancer metabolism. Only through understanding the relevance between lncRNAs and cancer metabolic reprogramming can we open a new chapter in the history of carcinogenesis, one that promises to alter the methods of cancer diagnosis and treatment.
Copyright © 2021 The American Society of Gene and Cell Therapy. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  cancer metabolism; lncRNA; regulatory mechanism; reprogramming

Mesh:

Substances:

Year:  2021        PMID: 33775912      PMCID: PMC8261164          DOI: 10.1016/j.ymthe.2021.03.017

Source DB:  PubMed          Journal:  Mol Ther        ISSN: 1525-0016            Impact factor:   12.910


  107 in total

1.  SNHG16 is regulated by the Wnt pathway in colorectal cancer and affects genes involved in lipid metabolism.

Authors:  Lise Lotte Christensen; Kirsten True; Mark P Hamilton; Morten M Nielsen; Nkerorema D Damas; Christian K Damgaard; Halit Ongen; Emmanouil Dermitzakis; Jesper B Bramsen; Jakob S Pedersen; Anders H Lund; Søren Vang; Katrine Stribolt; Mogens R Madsen; Søren Laurberg; Sean E McGuire; Torben F Ørntoft; Claus L Andersen
Journal:  Mol Oncol       Date:  2016-06-26       Impact factor: 6.603

Review 2.  Targeting long non-coding RNA to therapeutically upregulate gene expression.

Authors:  Claes Wahlestedt
Journal:  Nat Rev Drug Discov       Date:  2013-06       Impact factor: 84.694

3.  THE CHEMICAL CONSTITUTION OF RESPIRATION FERMENT.

Authors:  O Warburg
Journal:  Science       Date:  1928-11-09       Impact factor: 47.728

4.  Competitive endogenous RNAs cannot alter microRNA function in vivo.

Authors:  Jennifer A Broderick; Phillip D Zamore
Journal:  Mol Cell       Date:  2014-06-05       Impact factor: 17.970

Review 5.  Q's next: the diverse functions of glutamine in metabolism, cell biology and cancer.

Authors:  R J DeBerardinis; T Cheng
Journal:  Oncogene       Date:  2009-11-02       Impact factor: 9.867

Review 6.  MYC-induced cancer cell energy metabolism and therapeutic opportunities.

Authors:  Chi V Dang; Anne Le; Ping Gao
Journal:  Clin Cancer Res       Date:  2009-10-27       Impact factor: 12.531

7.  A Peptide Encoded by a Putative lncRNA HOXB-AS3 Suppresses Colon Cancer Growth.

Authors:  Jin-Zhou Huang; Min Chen; Xing-Cheng Gao; Song Zhu; Hongyang Huang; Min Hu; Huifang Zhu; Guang-Rong Yan
Journal:  Mol Cell       Date:  2017-10-05       Impact factor: 17.970

Review 8.  Gene regulation by the act of long non-coding RNA transcription.

Authors:  Aleksandra E Kornienko; Philipp M Guenzl; Denise P Barlow; Florian M Pauler
Journal:  BMC Biol       Date:  2013-05-30       Impact factor: 7.431

9.  LncRNA GLCC1 promotes colorectal carcinogenesis and glucose metabolism by stabilizing c-Myc.

Authors:  Jiayin Tang; Tingting Yan; Yujie Bao; Chaoqin Shen; Chenyang Yu; Xiaoqiang Zhu; Xianglong Tian; Fangfang Guo; Qian Liang; Qiang Liu; Ming Zhong; Jinxian Chen; Zhizheng Ge; Xiaobo Li; Xiaoyu Chen; Yun Cui; Yingxuan Chen; Weiping Zou; Haoyan Chen; Jie Hong; Jing-Yuan Fang
Journal:  Nat Commun       Date:  2019-08-02       Impact factor: 14.919

Review 10.  The role of long noncoding RNAs in hepatocellular carcinoma.

Authors:  Zhao Huang; Jian-Kang Zhou; Yong Peng; Weifeng He; Canhua Huang
Journal:  Mol Cancer       Date:  2020-04-15       Impact factor: 27.401

View more
  11 in total

1.  Restoring the epigenetically silenced lncRNA COL18A1-AS1 represses ccRCC progression by lipid browning via miR-1286/KLF12 axis.

Authors:  Yuenan Liu; Jun Wang; Yi Shou; Wenjie Xu; Ziwei Huang; Jiaju Xu; Kailei Chen; Jingchong Liu; Di Liu; Huageng Liang; Hongmei Yang; Xiaoping Zhang
Journal:  Cell Death Dis       Date:  2022-07-04       Impact factor: 9.685

2.  The lncRNA ZFAS1 regulates lipogenesis in colorectal cancer by binding polyadenylate-binding protein 2 to stabilize SREBP1 mRNA.

Authors:  Huishan Wang; Yuli Chen; Yanwen Liu; Qiuhui Li; Jing Luo; Li Wang; Yuanyuan Chen; Chen Sang; Wen Zhang; Xianxiu Ge; Zhifeng Yao; Lin Miao; Xianghua Liu
Journal:  Mol Ther Nucleic Acids       Date:  2021-12-11       Impact factor: 8.886

Review 3.  Interplay Among Metabolism, Epigenetic Modifications, and Gene Expression in Cancer.

Authors:  Miaomiao Huo; Jingyao Zhang; Wei Huang; Yan Wang
Journal:  Front Cell Dev Biol       Date:  2021-12-24

4.  Comprehensive Analysis of Necroptosis-Related Long Noncoding RNA Immune Infiltration and Prediction of Prognosis in Patients With Colon Cancer.

Authors:  Li Liu; Liu Huang; Wenzheng Chen; Guoyang Zhang; Yebei Li; Yukang Wu; Jianbo Xiong; Zhigang Jie
Journal:  Front Mol Biosci       Date:  2022-02-14

5.  Chemotoxicity-induced exosomal lncFERO regulates ferroptosis and stemness in gastric cancer stem cells.

Authors:  Haiyang Zhang; Meng Wang; Yi He; Ting Deng; Rui Liu; Weixue Wang; Kegan Zhu; Ming Bai; Tao Ning; Haiou Yang; Ying Liu; Junyi Wang; Yi Ba
Journal:  Cell Death Dis       Date:  2021-11-29       Impact factor: 8.469

6.  lncRNA ZFAS1 Promotes HMGCR mRNA Stabilization via Binding U2AF2 to Modulate Pancreatic Carcinoma Lipometabolism.

Authors:  Luoluo Wang; Yi Ruan; Xiang Wu; Xinhua Zhou
Journal:  J Immunol Res       Date:  2022-07-08       Impact factor: 4.493

7.  Overexpression of lncRNAs with endogenous lengths and functions using a lncRNA delivery system based on transposon.

Authors:  Yin Zhang; Yong-Xin Huang; Xin Jin; Jie Chen; Li Peng; Dan-Lan Wang; Yun Li; Xin-Yi Yao; Jian-You Liao; Jie-Hua He; KaiShun Hu; Daning Lu; Yabin Guo; Dong Yin
Journal:  J Nanobiotechnology       Date:  2021-10-02       Impact factor: 10.435

8.  Comprehensive analyses of glycolysis-related lncRNAs for ovarian cancer patients.

Authors:  Jianfeng Zheng; Jialu Guo; Linling Zhu; Ying Zhou; Jinyi Tong
Journal:  J Ovarian Res       Date:  2021-09-24       Impact factor: 4.234

9.  LncRNA RP11-89 facilitates tumorigenesis and ferroptosis resistance through PROM2-activated iron export by sponging miR-129-5p in bladder cancer.

Authors:  Wenjie Luo; Jun Wang; Wenhao Xu; Chunguang Ma; Fangning Wan; Yongqiang Huang; Mengfei Yao; Hailiang Zhang; Yuanyuan Qu; Dingwei Ye; Yiping Zhu
Journal:  Cell Death Dis       Date:  2021-11-02       Impact factor: 8.469

10.  LncRNA RPSAP52 promotes cell proliferation and inhibits cell apoptosis via modulating miR-665/STAT3 in gastric cancer.

Authors:  Chao He; Yuanyuan Liu; Jinhou Li; Xiao Zheng; Jianwei Liang; Gang Cui; Hong Chang
Journal:  Bioengineered       Date:  2022-04       Impact factor: 6.832

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.